{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:59:03Z","timestamp":1793627943771,"version":"4.5.1"},"reference-count":111,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>The biological effects of the bisphosphonates (BPs) as inhibitors of calcification and bone resorption were first described in the late 1960s. In the 50 years that have elapsed since then, the BPs have become the leading drugs for the treatment of skeletal disorders characterized by increased bone resorption, including Paget's disease of bone, bone metastases, multiple myeloma, osteoporosis and several childhood inherited disorders. The discovery and development of the BPs as a major class of drugs for the treatment of bone diseases is a paradigm for the successful journey from \u201cbench to bedside and back again\u201d. Several of the leading BPs achieved \u201cblockbuster\u201d status as branded drugs. However, these BPs have now come to the end of their patent life, making them highly affordable. The opportunity for new clinical applications for BPs also exists in other areas of medicine such as ageing, cardiovascular disease and radiation protection. Their use as inexpensive generic medicines is therefore likely to continue for many years to come. Fifty years of research into the pharmacology of bisphosphonates have led to a fairly good understanding about how these drugs work and how they can be used safely in patients with metabolic bone diseases. However, while we seemingly know much about these drugs, a number of key aspects related to BP distribution and action remain incompletely understood. This review summarizes the existing knowledge of the (pre)clinical and translational pharmacology of BPs, and highlights areas in which understanding is lacking.<\/jats:p>","DOI":"10.1111\/bcp.13867","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T15:58:48Z","timestamp":1547654328000},"page":"1052-1062","source":"Crossref","is-referenced-by-count":205,"title":["Pharmacology of bisphosphonates"],"prefix":"10.1111","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6800-5532","authenticated-orcid":false,"given":"Serge","family":"Cremers","sequence":"first","affiliation":[{"name":"Division of Laboratory Medicine, Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons Columbia University Irving Medical Center  New York NY USA"},{"name":"Division of Endocrinology, Department of Medicine, Vagelos College of Physicians and Surgeons Columbia University Irving Medical Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3662-7345","authenticated-orcid":false,"given":"Matthew T.","family":"Drake","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Kogod Center of Aging Mayo Clinic College of Medicine  Rochester MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Hal","family":"Ebetino","sequence":"additional","affiliation":[{"name":"Department of Chemistry University of Rochester  Rochester NY USA"},{"name":"Mellanby Centre for Bone Research, Medical School University of Sheffield  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Vagelos College of Physicians and Surgeons Columbia University Irving Medical Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Graham G.","family":"Russell","sequence":"additional","affiliation":[{"name":"Mellanby Centre for Bone Research, Medical School University of Sheffield  UK"},{"name":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences The Oxford University Institute of Musculoskeletal Sciences, The Botnar Research Centre, Nuffield Orthopaedic Centre  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152012799014959"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.165.3899.1262"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.165.3899.1264"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/223211a0"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.05.019"},{"key":"e_1_2_7_7_1","first-page":"CD004956","article-title":"Bisphosphonates for Paget's disease of bone in adults","volume":"12","author":"Corral\u2010Gudino L","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2018.03.011"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2018.06.007"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01615"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030154"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0540-8"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.04.022"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(95)00445-9"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/mi.10.3.5"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544060-00001"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.01.014"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.03.774"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.115724"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006286781"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1999.14.5.784"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(01)00589-0"},{"key":"e_1_2_7_23_1","first-page":"196","article-title":"Bisphosphonate\u2010induced gastrointestinal mucosal injury is mediated by mitochondrial superoxide production and lipid peroxidation","volume":"51","author":"Nagano Y","year":"2012","journal-title":"J Clin Biochem Nutr"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90245-7"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1791-y"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04304.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007301801"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270002239824"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)90602-3"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050817"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.070112"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.7.1281"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00569.x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.12.2266"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2007.00271.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(96)00182-2"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(94)00035-X"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.021071"},{"issue":"3","key":"e_1_2_7_40_1","first-page":"270","article-title":"The use of whole\u2010body retention of Tc\u201099m diphosphonate in the diagnosis of metabolic bone disease","volume":"19","author":"Fogelman I","year":"1978","journal-title":"J Nucl Med"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.06.037"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.05.003"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1543"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm7015733"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040920"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.10.1700"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.5.868"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050522"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02224.x"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/009127002762491316"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.12.225"},{"key":"e_1_2_7_52_1","unstructured":"CoxonFPT ThompsonK HughesA EbetinoFH RogersMJ. Resorbing osteoclasts increase the availability of mineral\u2010bound bisphosphonates to non\u2010resorbing cells.ASBMR Meeting 2005 Poster 2005."},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.4.581"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1499"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0224"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033453640"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc062792"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.06.027"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650070507"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4460-6"},{"key":"e_1_2_7_61_1","first-page":"S81","article-title":"Head\u2010to\u2010head comparison of risedronate and alendronate pharmacokinetics at clinical doses","volume":"34","author":"Phipps R","year":"2004","journal-title":"Bone"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(98)00120-3"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0601643103"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3138"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2010.08.008"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080617"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28965"},{"issue":"11","key":"e_1_2_7_68_1","first-page":"2949","article-title":"Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases","volume":"60","author":"Boissier S","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.1727"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70302-X"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13852"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13834"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-016-1224-8"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1066-7"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10738"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glt046"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02555208"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6609.1301"},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1999.14.9.1557"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010101)91:1<144::AID-CNCR19>3.0.CO;2-Q"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(09)80009-4"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650080202"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.7.1398"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650111021"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666160-00001"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090526"},{"key":"e_1_2_7_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0174-3"},{"key":"e_1_2_7_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-002-2011-8"},{"issue":"1","key":"e_1_2_7_89_1","first-page":"1","article-title":"Therapeutic equivalence of alendronate 70 mg once\u2010weekly and alendronate 10 mg daily in the treatment of osteoporosis","volume":"12","author":"Schnitzer T","year":"2000","journal-title":"Aging"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050313"},{"key":"e_1_2_7_91_1","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1097\/SCS.0000000000004224","article-title":"Cross\u2010sectional study of four serological bone turnover markers for the risk assessment of medication\u2010related osteonecrosis of the jaw","volume":"29","author":"Peisker A","year":"2018","journal-title":"J Craniofac Surg"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05770.x"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2015.09.028"},{"key":"e_1_2_7_94_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP12425.OR"},{"key":"e_1_2_7_95_1","doi-asserted-by":"publisher","DOI":"10.11005\/jbm.2013.20.1.31"},{"key":"e_1_2_7_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13012"},{"key":"e_1_2_7_97_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP171781.OR"},{"key":"e_1_2_7_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3051"},{"key":"e_1_2_7_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2016.59"},{"key":"e_1_2_7_100_1","doi-asserted-by":"publisher","DOI":"10.2165\/11318150-000000000-00000"},{"key":"e_1_2_7_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12135"},{"key":"e_1_2_7_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-011-9224-2"},{"key":"e_1_2_7_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2009.08.053"},{"key":"e_1_2_7_104_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011412967"},{"key":"e_1_2_7_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2012.15"},{"key":"e_1_2_7_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-017-9551-z"},{"key":"e_1_2_7_107_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074941"},{"key":"e_1_2_7_108_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808082"},{"key":"e_1_2_7_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1792"},{"key":"e_1_2_7_110_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1786"},{"key":"e_1_2_7_111_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.008285"},{"key":"e_1_2_7_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2255"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.13867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.13867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.13867","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.13867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T03:14:31Z","timestamp":1694315671000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.13867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":111,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1111\/bcp.13867"],"URL":"https:\/\/doi.org\/10.1111\/bcp.13867","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]}}}